Dra Elina Yamul

Dra Elina Yamul

About

Detail

Médica Especialista en Otorrinolaringología & Sub-investigadora Clínica de Protocolos Médicos
Buenos Aires, Argentina

Contact Dra regarding: 
work
Full-time jobs

Timeline


work
Job
school
Education
folder
Project

Résumé


Jobs verified_user 0% verified
  • H
    Sub investigator
    Hospital Italiano de La Plata.
    Jan 2023 - Current (3 years 10 months)
    Study coordination activities, data base completion oversight, evaluation on patients with rheumatology diseases enrrolled in clinical traials, adverse events and serious adverse events reporting.
  • S
    ENT
    Sanatorio Anchorena.
    Nov 2022 - Current (4 years)
    I treat, operate and monitor patients with head and neck tumors
  • OFO
    Dentist
    OFO
    May 2001 - Mar 2020 (18 years 11 months)
    Diagnóstico Temprano Y tratamiento posterior de patologías buco maxilofaciales
Education verified_user 0% verified
  • E
    ENT Private Practice.
    Jun 2019 - Current (7 years 5 months)
  • N
    Certificate of completion "Good Clinical Practice".
    NIDA Clinical Trials Network.
    Mar 1988 - Dec 1994 (6 years 10 months)
  • E
    ENT
  • U
    ENT Specialist: Resident of
    Universidad Católica Argentina.
  • U
    Medical Doctor.
    Universidad Nacional de La Plata. School of Medicine.
  • F
    Approved monitoring course
    FEFYM (Fundación de Estudio Farmacológico
Projects (professional or personal) verified_user 0% verified
  • E
    Evaluación de nuevos medicamentos
    Empresas farmaceuticas
    Jan 2025 - Current (1 year 10 months)
    Evaluar reportar y notificar efectos adversos de medicamentos en protocolos de Investigacion
  • ICONIC
    Galapagos
    J
    Novartis Research and Development.
    ICONIC, Galapagos, JANSSEN, Novartis
    May 2023 - Current (3 years 6 months)
    A phase 2, multicenter, multinational, randomized, double-blind, placebo controlled study to assess the safety, efficacy, and pharmacokinetics of multiple dose levels of ESK-001 in adult patients with systemic lupus erythematosus. 77242113PSO3001 A Phase 3 multicenter, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of JNJ-77242113 for the treatment of participants with moderate to severe plaque psoriasis with randomized withdrawal and retreatment. (VAY736). Clinical Trial Protocol A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in participants with active lupus ne
  • H
    Protocol GLPG3667-CL-215
    Hospital Italiano
    May 2023 - Current (3 years 6 months)
    Sub investigadora